Fisher & Paykel Healthcare Corporation Limited
FSPKF
$20.70
$2.3412.75%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 303.63M | 315.90M | 290.78M | 287.76M | 287.59M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 303.63M | 315.90M | 290.78M | 287.76M | 287.59M |
| Cost of Revenue | 110.01M | 114.45M | 110.82M | 109.66M | 116.62M |
| Gross Profit | 193.62M | 201.44M | 179.96M | 178.09M | 170.97M |
| SG&A Expenses | 77.74M | 80.88M | 79.63M | 78.81M | 78.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 220.90M | 229.82M | 224.11M | 221.78M | 226.10M |
| Operating Income | 82.73M | 86.08M | 66.67M | 65.98M | 61.49M |
| Income Before Tax | 84.27M | 87.67M | 63.10M | 62.44M | 29.12M |
| Income Tax Expenses | 20.69M | 21.53M | 16.26M | 16.09M | 21.38M |
| Earnings from Continuing Operations | 63.58M | 66.14M | 46.83M | 46.35M | 7.75M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 63.58M | 66.14M | 46.83M | 46.35M | 7.75M |
| EBIT | 82.73M | 86.08M | 66.67M | 65.98M | 61.49M |
| EBITDA | 98.43M | 102.41M | 84.28M | 83.41M | 75.46M |
| EPS Basic | 0.11 | 0.11 | 0.08 | 0.08 | 0.01 |
| Normalized Basic EPS | 0.09 | 0.09 | 0.07 | 0.07 | 0.06 |
| EPS Diluted | 0.11 | 0.11 | 0.08 | 0.08 | 0.01 |
| Normalized Diluted EPS | 0.09 | 0.09 | 0.07 | 0.07 | 0.06 |
| Average Basic Shares Outstanding | 586.13M | 586.13M | 584.95M | 584.95M | 583.36M |
| Average Diluted Shares Outstanding | 591.01M | 591.01M | 589.39M | 589.39M | 587.82M |
| Dividend Per Share | 0.07 | 0.07 | 0.06 | 0.06 | 0.07 |
| Payout Ratio | 42.92% | 42.92% | 47.04% | 47.04% | 205.61% |